CONDITION

Oral Melanoma

Oral melanoma is a tumour that arises from pigment-producing cells in the mouth. In dogs, these growths tend to behave aggressively, often spreading to nearby tissue and, in many cases, to other parts of the body. In cats, oral melanomas are less common and may behave differently. Owners often first notice a dark mass on the gums, tongue, or roof of the mouth, though not all oral melanomas are pigmented. Some animals may have difficulty eating, bleeding from the mouth, or a noticeable change in breath. In other cases, a growth is found during a routine examination before any signs appear. This page explores what oral melanoma can look like when first observed, what is happening at a cellular level, how the condition is investigated through imaging and sampling, and what approaches exist for managing it. The aim is to help owners understand the nature of the condition and the decisions that may follow.

Why this matters now

Oral melanoma in dogs tends to appear in middle-aged to older animals, with most cases diagnosed between nine and twelve years of age. Certain breeds, including Cocker Spaniels, Poodles, Gordon Setters, and Golden Retrievers, appear over-represented in some surveys, though the condition can occur in any breed. Dogs with darkly pigmented oral tissue may carry a higher background risk. In cats, oral melanoma is encountered much less frequently and the age and breed patterns are less clearly defined.

In dogs, oral melanoma often behaves as a locally invasive tumour, extending into surrounding bone and soft tissue over weeks to months. Spread to regional lymph nodes in the neck can occur relatively early in the disease course, and distant spread to the lungs or other organs may follow. The rate of progression varies between individuals, and some tumours remain confined to the original site for longer than others. In cats, the behaviour can be less predictable, with some lesions showing slower progression than is typical in dogs.

Signals & patterns

Early signals

Visible dark mass in mouth

An owner may notice a raised, pigmented growth on the gums, tongue, palate, or inner cheek during play, tooth-brushing, or when the animal yawns. Not all oral melanomas are heavily pigmented, and some appear pink or red, making them less distinctive against normal tissue.

Blood-tinged saliva or drooling

A small amount of blood may appear in saliva, on toys, or where the animal has been lying. This can occur when the tumour surface becomes ulcerated or when the animal's teeth or tongue rub against the growth during normal mouth activity.

Altered chewing or eating pattern

The animal may chew on one side of the mouth, drop food, or take longer to finish meals. This can reflect discomfort or physical obstruction caused by the mass, though many animals continue eating normally in the early stages.

Halitosis with a different character

Breath odour may change, often becoming more unpleasant or developing a distinct quality. This can result from tissue breakdown, secondary bacterial colonisation of the tumour surface, or accumulated debris around the growth.

Later signals

Facial swelling or asymmetry

As the tumour invades deeper tissue or bone, swelling may become visible on the outside of the face or jaw. This may be accompanied by loosening of teeth in the affected area or visible distortion of the muzzle.

Difficulty closing the mouth

Larger tumours can interfere with normal jaw mechanics, making it harder for the animal to close the mouth fully or to hold the tongue in a comfortable position. This may lead to persistent drooling or a change in the way the animal holds its head.

Firm lumps under the jaw or neck

Enlarged lymph nodes may become palpable as firm, rounded swellings beneath the skin in the neck region. These can indicate that tumour cells have travelled to the regional lymphatic system, though not all enlarged nodes contain cancer.

Click to read about the biological mechanisms

How this is usually investigated

Investigation typically begins with a physical examination of the oral cavity, noting the size, location, and appearance of any mass, along with an assessment of regional lymph nodes. Sampling of the lesion itself is often pursued to characterise the cell type and confirm the diagnosis. Imaging studies can help define the extent of local involvement and assess for spread to distant sites, shaping the overall picture of the disease.

Fine-needle aspiration or biopsy

Purpose: A sample of cells or tissue from the mass allows examination under the microscope to confirm whether melanoma is present and to assess features such as pigmentation and cellular architecture. This step distinguishes oral melanoma from other growths that may appear similar on visual inspection.
Considerations: Fine-needle aspiration can sometimes yield insufficient material for confident diagnosis, particularly if the tumour is poorly pigmented or contains areas of necrosis. Biopsy under sedation or anaesthesia may be required for a more definitive sample, and some tumours are situated in locations that make sampling technically more challenging.

Regional lymph node assessment

Purpose: Palpation and often sampling of the lymph nodes beneath the jaw and in the neck can reveal whether tumour cells have spread from the original site. This information contributes to understanding the extent of disease at the time of diagnosis.
Considerations: Lymph nodes may be enlarged for reasons other than tumour spread, including local inflammation or infection. Even normal-sized nodes can harbour microscopic metastases, so absence of enlargement does not rule out spread.

Thoracic imaging

Purpose: Radiography or computed tomography of the chest is often performed to look for evidence of spread to the lungs, one of the more common distant sites for oral melanoma metastasis. The presence or absence of visible lesions can influence management decisions.
Considerations: Very small metastases may not be visible on radiographs and can sometimes be detected only on more detailed imaging such as CT. A clear scan at one point in time does not guarantee that spread will not occur later.

Imaging of the local site

Purpose: Computed tomography or, less commonly, magnetic resonance imaging of the skull and oral cavity can show the extent of tumour invasion into bone and adjacent soft tissue. This detail can inform planning for surgical removal and help anticipate the degree of reconstruction that may be required.
Considerations: Advanced imaging requires general anaesthesia and access to specialist equipment, which may not be available at all practices. The images provide a snapshot of anatomy at a single moment and do not predict how rapidly the tumour will progress.

Blood biochemistry and haematology

Purpose: Routine blood tests are often performed before anaesthesia or treatment to assess organ function and general health. They do not diagnose melanoma but can identify concurrent conditions that may influence management choices.
Considerations: These tests are non-specific and usually unremarkable in cases of oral melanoma unless there is unrelated disease or, occasionally, effects from advanced metastatic spread.

Options & trade-offs

Management of oral melanoma in dogs often involves a combination of local treatment, systemic therapy, and monitoring for progression or spread. The approach chosen depends on the location and extent of the tumour, the presence or absence of metastasis, the animal's overall health, and what is practical for the household. Different combinations suit different situations, and no single path is applicable to all cases.

Surgical removal

Surgery aims to remove the tumour along with a margin of surrounding normal tissue to reduce the chance of local recurrence. In some cases, this may involve resection of part of the jaw or palate, particularly when the tumour has invaded bone. Reconstruction techniques can be used to maintain function and appearance where possible.

Trade-offs: The extent of surgery required depends on tumour location and size, and some resections carry implications for eating, drinking, or facial symmetry. Surgery addresses the local disease but does not prevent metastasis that has already occurred or may develop later. Recovery from major oral surgery can take weeks, and some animals may need feeding support during that period.

Radiation therapy

Radiation can be directed at the primary tumour site, either as a sole treatment or following surgery, to control local disease. It may also be used to target regional lymph nodes if spread is detected. Treatment typically involves multiple sessions over several weeks, each requiring a short general anaesthetic.

Trade-offs: Radiation therapy requires access to a specialist centre and repeated anaesthesia, which may not be practical for all owners or animals. Side effects can include inflammation of the oral mucosa, difficulty eating, and, over time, tissue changes such as bone damage or delayed wound healing. Radiation does not address distant metastases that may be present or develop later.

Immunotherapy

Vaccines designed to stimulate an immune response against melanoma cells have been used in dogs, often in combination with surgery or radiation. The approach is based on training the immune system to recognise and target tumour-associated proteins. Treatment usually involves an initial series of injections followed by periodic boosters.

Trade-offs: The effectiveness of immunotherapy varies between individuals, and it is not a substitute for local control of the primary tumour. Availability may be limited by geography and regulatory approval. Side effects are generally mild but can include injection site reactions or, occasionally, immune-mediated conditions.

Chemotherapy

Systemic chemotherapy has been explored in oral melanoma, though responses tend to be less predictable than in some other tumour types. Drugs may be used when metastatic disease is present or when other treatments are not feasible. Protocols vary and are often tailored to the individual case.

Trade-offs: Oral melanoma in dogs often shows limited sensitivity to chemotherapy, and the benefit in terms of survival time can be modest. Side effects depend on the drugs used and can include gastrointestinal upset, suppression of bone marrow function, and increased susceptibility to infection. Chemotherapy is typically considered when the goal is to slow progression rather than to cure.

Supportive and palliative care

When curative treatment is not pursued or is no longer effective, management can focus on maintaining comfort and quality of life. This may include pain relief, anti-inflammatory medication, assistance with eating, and monitoring for signs that the disease is causing distress. The aim is to support the animal through the time available rather than to alter the course of the disease.

Trade-offs: Palliative care does not slow tumour growth or prevent metastasis, and there may come a point when the disease causes problems that cannot be managed comfortably. This approach requires ongoing assessment and a willingness to adjust the plan as the animal's needs change.

Common misconceptions

Misconception:

"All dark masses in the mouth are melanomas."

Reality:

Pigmentation in the oral cavity can arise from benign causes, including normal variation in mucosal colour, areas of harmless pigment accumulation, or other non-cancerous growths. A dark mass may also represent a different type of tumour, and microscopic examination is needed to distinguish between possibilities. Not all melanomas are darkly pigmented, and some appear pink or unpigmented, so colour alone does not confirm or exclude the diagnosis.

Misconception:

"Removing the tumour surgically will cure the disease."

Reality:

Surgery can remove the visible mass and reduce the chance of local recurrence if adequate margins are achieved, but it does not prevent metastasis that has already occurred at a microscopic level or may develop later. Oral melanoma in dogs often spreads to lymph nodes or distant organs, and many cases will show progression despite successful local control. Surgery is often one part of a broader management plan rather than a standalone cure.

Misconception:

"If the dog seems well and is eating normally, the melanoma cannot be serious."

Reality:

Dogs with oral melanoma can appear comfortable and maintain normal behaviour in the early stages, particularly if the tumour is small or located in a less sensitive area of the mouth. Absence of obvious signs does not reflect the biological behaviour of the tumour, and spread to lymph nodes or lungs can occur before any change in demeanour is noticed. The degree of clinical signs often lags behind the progression of the disease.

Related conditions

Squamous Cell Carcinoma

Squamous cell carcinoma is another malignant tumour that can develop in the mouth, particularly affecting the gums, tongue, and tonsils. In cases where a mass is found in the oral cavity, distinguishing between melanoma and squamous cell carcinoma often requires microscopic examination of tissue samples.

Osteosarcoma

Osteosarcoma and oral melanoma share an aggressive biological behaviour, with both tumours tending to spread to distant sites—most commonly the lungs—relatively early in their course. The principles of staging and treatment planning often overlap, particularly when assessing for distant spread through imaging.

Dental Disease in Cats

Dental disease in cats can cause oral discomfort, bleeding, and difficulty eating, signs that may also appear when an oral tumour is present. In some cases, a mass may only be noticed during examination of the mouth prompted by these overlapping signs.

Dental Disease in Dogs

Dental disease in dogs can produce similar signs to oral melanoma, including halitosis, oral bleeding, and reluctance to eat, and chronic inflammation in the mouth may occasionally prompt closer inspection that reveals a previously unnoticed mass. The presence of severe periodontal disease does not exclude the possibility of a concurrent tumour.

Lymphoma in Dogs

Lymphoma can occasionally involve the oral cavity, gums, or tonsils, presenting as masses or swellings that may initially be difficult to distinguish from melanoma or other tumours without tissue sampling. Both conditions are managed in the context of systemic cancer care, though their cellular origins and treatment approaches differ.

Understanding the nature of oral melanoma and the range of approaches available can help shape conversations about what might be practical for an individual animal. The Longevity & Healthspan pillar includes related discussions on managing conditions in older dogs and the considerations that arise when balancing intervention with quality of life. If a diagnosis has been made, the pattern of disease at the time of investigation often informs which combinations of treatment may be relevant to explore in more detail.

Last reviewed: 1 July 2026 · Dr Alastair Greenway MRCVS